ENDONOVO THERAPEUTICS, INC.

WOODLAND HILLS, CA · Founded 2011 · Medtech · Public

Non-invasive wearable electroceutical devices that deliver proprietary electrical stimulation therapy for inflammatory, cardiovascular, and neurological conditions

Claim this profile

Follows are private to you and power your alerts

Updated · endonovo.com

Sector
Medtech
Headquarters
WOODLAND HILLS, CA
Founded
2011
Latest Form D
$225K, Nov 2019
Total capital
$1.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.3M
7 Form D · last Nov 2019
83 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
5
7 pending · first 2019
Rank in peer group#304 of 1112

Capital timeline

2013201420152016201720182019FEDERAL ↑EQUITY ↓Cumulative $1.3M4th Form D$105K5th Form D$211K6th Form D$700K
2013201520172019FEDERAL ↑EQUITY ↓Cumulative $1.3M

Latest events

  • Private capital raisedForm D · SEC · 7th filing$225K
  • Private capital raisedForm D · SEC · 6th filing$700K
  • Private capital raisedForm D · SEC · 5th filing$211K
  • Private capital raisedForm D · SEC · 4th filing$105K
  • Private capital raisedForm D · SEC · 3rd filing$13K
  • Private capital raisedForm D · SEC · 2nd filing$25K
  • Private capital raisedForm D · SEC · 1st filing$10K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#304 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Alan CollierExecutive Officer, DirectorNamed in SEC Form D filings
  • CollierExecutive Officer, DirectorNamed in SEC Form D filings
  • Michael MannExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 12
  • PendingMethod For Treatment Of Non-alcoholic Steatohepatitis Using Pulsed Electromagnetic Field TherapyUSPTOApplication 16657827
  • GrantedMethod And Apparatus For Electromagnetic Treatment Of Multiple SclerosisUSPTOUS 10,556,121
  • PendingMethod and Apparatus for Electromagnetic Treatment of Living SystemsUSPTOApplication 16431561
Show all 12 patent records
  • MOREMME VA LLCSimilar federal contract value in Medtech · null in contracts
  • LUCIE MEDICAL INCSimilar federal contract value in Medtech · null in contracts
  • VELLUM BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
  • Magnus Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • Avivomed Inc.Similar federal contract value in Medtech · null in contracts
  • DurVena, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .